Cordyceps Sunshine Biotech Holdings Balans Gezondheid
Financiële gezondheid criteriumcontroles 2/6
Cordyceps Sunshine Biotech Holdings has a total shareholder equity of $-78.7K and total debt of $445.3K, which brings its debt-to-equity ratio to -565.6%. Its total assets and total liabilities are $3.4M and $3.5M respectively. Cordyceps Sunshine Biotech Holdings's EBIT is $225.4K making its interest coverage ratio 8.5. It has cash and short-term investments of $15.3K.
Belangrijke informatie
-565.6%
Verhouding schuld/eigen vermogen
US$445.28k
Schuld
| Rente dekkingsratio | 8.5x |
| Contant | US$15.28k |
| Aandelen | -US$78.73k |
| Totaal verplichtingen | US$3.50m |
| Totaal activa | US$3.42m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: RAJA.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Langlopende schulden: RAJA.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: RAJA.F has negative shareholder equity, which is a more serious situation than a high debt level.
Schuld verminderen: RAJA.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Schuldendekking: RAJA.F's debt is well covered by operating cash flow (72.9%).
Rentedekking: RAJA.F's interest payments on its debt are well covered by EBIT (8.5x coverage).